Who owns Neumora Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of NMRA from SEC Form 13F filings across 113 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 113 institutions disclosed 76.0M shares of Neumora Therapeutics, Inc. worth $129.2M — about 41% of shares outstanding; the largest disclosed holder is Siren, L.L.C.. Source: SEC Form 13F filings, parsed by EvidInvest.
113
13F holders
$129.2M
value, 2026 filers
41%
of shares outstanding (76.0M sh)
28
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of NMRA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Siren, L.L.C. | 8.5M | $14.4M | 0.3% | 4.6% | 0.0% |
| 2 | BlackRock, Inc. | 7.8M | $13.2M | 0.0% | 4.2% | +279.3% |
| 3 | SOFTBANK GROUP CORP. | 6.1M | $10.4M | 0.1% | 3.3% | 0.0% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 4.7M | $7.9M | 0.0% | 2.5% | +20.0% |
| 5 | MIC Capital Management UK LLP | 4.5M | $7.6M | 1.9% | 2.4% | 0.0% |
| 6 | FMR LLC | 3.5M | $5.9M | 0.0% | 1.9% | 0.0% |
| 7 | WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 3.3M | $5.6M | 0.1% | 1.8% | 0.0% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.6M | $4.4M | 0.0% | 1.4% | +139.9% |
| 9 | ICONIQ Capital, LLC | 2.6M | $4.4M | 0.1% | 1.4% | 0.0% |
| 10 | TWO SIGMA INVESTMENTS, LP | 2.2M | $3.8M | 0.0% | 1.2% | +10.2% |
| 11 | ORBIMED ADVISORS LLCNEW | 2.1M | $3.6M | 0.1% | 1.2% | new |
| 12 | Lunate Capital Ltd | 2.1M | $3.6M | 1.8% | 1.1% | 0.0% |
| 13 | Boxer Capital Management, LLCNEW | 2.0M | $3.4M | 0.3% | 1.1% | new |
| 14 | JOHNSON & JOHNSON | 1.8M | $3.1M | 0.4% | 1% | 0.0% |
| 15 | STATE STREET CORP | 1.6M | $2.7M | 0.0% | 0.9% | +296.8% |
| 16 | TUDOR INVESTMENT CORP ET AL | 1.4M | $2.3M | 0.0% | 0.7% | +75.8% |
| 17 | Ikarian Capital, LLC | 1.3M | $2.2M | 0.2% | 0.7% | 0.0% |
| 18 | RENAISSANCE TECHNOLOGIES LLC | 1.3M | $2.1M | 0.0% | 0.7% | -9.1% |
| 19 | Affinity Asset Advisors, LLCNEW | 1.1M | $1.8M | 0.1% | 0.6% | new |
| 20 | MARSHALL WACE, LLP | 904,458 | $1.5M | 0.0% | 0.5% | -24.3% |
| 21 | VANGUARD PORTFOLIO MANAGEMENT LLC | 894,791 | $1.5M | 0.0% | 0.5% | +384.1% |
| 22 | CITADEL ADVISORS LLC | 828,933 | $1.4M | 0.0% | 0.4% | +141.3% |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 823,583 | $1.4M | 0.0% | 0.4% | +59.6% |
| 24 | NORTHERN TRUST CORP | 800,571 | $1.4M | 0.0% | 0.4% | +306.6% |
| 25 | Ensign Peak Advisors, IncNEW | 784,679 | $1.3M | 0.0% | 0.4% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.